» Articles » PMID: 33387224

The Association Between Platelet Indices and Cardiovascular Events in Chronic Kidney Disease Patients Without Dialysis

Overview
Publisher Springer
Specialty Nephrology
Date 2021 Jan 2
PMID 33387224
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Previous studies have indicated that platelet indices are related to the pathogenesis of cardiovascular diseases (CVD). However, it is unclear which platelet-related indicators are associated with CVD events in patients with chronic kidney disease (CKD) without dialysis.

Methods: We performed a single-center prospective cohort study involved 1391 CKD patients to explore the relationship between platelet indices and CVD events in CKD patients. A nomogram was generated to predict CVD-free survival after 3 and 5 years of follow-up in terms of the fitted Cox regression model. And the time-dependent receiver-operating characteristic (ROC) curves were applied to evaluate the prediction accuracy of platelet indices on CVD events.

Results: During a median follow-up of 3.41 years, 211 (15.2%) patients experienced CVD events. Results showed that platelet counts (PLT), plateletcrit (PCT), platelet-large cell ratio (P-LCR), and platelet distribution width (PDW) among 5 platelet indices were significantly lower in advanced CKD stages. Cox regression model showed that PLT, PDW, and PCT were associated with CVD events. However, after multivariable-adjusted, low level of PLT, hazard ratio (HR) 0.994 and 95% confidence interval (95% CI 0.989-1.000, p = 0.04), and PDW, HR 0.936 (95% CI 0.878-0.998, p = 0.044) predicted CVD events. The area under the ROC curve (AUC) of platelet indices assessed by time-dependent ROC curve analysis showed that only PLT and PDW were significant for predicting CVD events for 5 years.

Conclusions: We demonstrated that PLT and PDW among 5 platelet indices were independently associated with CVD events in patients with CKD.

Citing Articles

Are the Hematological Parameters Useful in Differentiating Acute Pyelonephritis from Cystitis in Patients with Chronic Kidney Disease?.

Dicu-Andreescu I, Garneata L, Ciurea O, Dicu-Andreescu I, Ungureanu E, Vlad D Maedica (Bucur). 2024; 19(3):511-518.

PMID: 39553351 PMC: 11565154. DOI: 10.26574/maedica.2024.19.3.511.


Association between perioperative platelet distribution width changes and postoperative acute kidney injury in patients with renal insufficiency: a retrospective study.

Su Y, Xu X, Luo Z, Fang Y, Gong S, Teng J BMC Nephrol. 2024; 25(1):393.

PMID: 39487450 PMC: 11531174. DOI: 10.1186/s12882-024-03802-9.


Systemic immune inflammation index and all-cause mortality in chronic kidney disease: A prospective cohort study.

Jia M, Yuan W, Chen Y, Wang Y, Shang L, Han S Immun Inflamm Dis. 2024; 12(9):e1358.

PMID: 39254488 PMC: 11386342. DOI: 10.1002/iid3.1358.


The impact of depression on platelet activation, cardiocerebral vascular events and arteriovenous fistula dysfunction in patients undergoing haemodialysis.

Xu Y, Zhang S, Xia W, Xiong Y, Wang X, Liu Y Sci Rep. 2024; 14(1):20569.

PMID: 39232077 PMC: 11375179. DOI: 10.1038/s41598-024-71490-4.


The relationship of platelet distribution width with all-cause and cardiovascular mortality in peritoneal dialysis patients.

Lu C, Cheng S, Fan W, Zhang Z, Wang J Ren Fail. 2024; 46(1):2300730.

PMID: 38343320 PMC: 10863511. DOI: 10.1080/0886022X.2023.2300730.


References
1.
Glassock R, Warnock D, Delanaye P . The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2016; 13(2):104-114. DOI: 10.1038/nrneph.2016.163. View

2.
Chen T, Knicely D, Grams M . Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019; 322(13):1294-1304. PMC: 7015670. DOI: 10.1001/jama.2019.14745. View

3.
Kahn M, Robbins M, Kim M, Fuster V . Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol. 2013; 10(5):261-73. DOI: 10.1038/nrcardio.2013.15. View

4.
van der Meijden P, Heemskerk J . Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2018; 16(3):166-179. DOI: 10.1038/s41569-018-0110-0. View

5.
AlJaroudi W, Halabi A, Harrington R . Platelet inhibitor therapy for patients with cardiovascular disease: looking toward the future. Curr Hematol Rep. 2005; 4(5):397-404. View